BD5-33866-26611
3 vaccinations
4 coded responses
25 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 802 / CO
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Survey response — days 1–6 daily, dose 1MedDRA: Myalgia — Feeling: GoodFree text: Mild soreness in deltoid with overhead reaching at timesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-08
-
2021-02-14
Dose 2 — Pfizer-BioNTech
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia oral, Paraesthesia oral — Feeling: Fair · Site: PainFree text: Didnt associate after the first vaccine, but after both vaccines my tongue was tingly and numb for about an hour after the vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-05-16
- 2021-08-15
-
2022-01-21
Dose 3 — Moderna
- 2022-02-14
-
2022-07-22
Survey response — 6 months, dose 3MedDRA: Gastrointestinal disorder, Inflammation, Injection site muscle atrophy, Nasal congestion, Upper respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Inflammation throughout my body (face, neck, abdomen, upper and lower extremities), increased GI issues, increased nasal and upper respiratory congestion, deterioration of the deltoid where the vaccine was administeredMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-25
-
2023-01-22
Survey response — 12 months, dose 3MedDRA: Dyspnoea, Heavy menstrual bleeding, Injection site muscle atrophy, Medical counselling, Menstrual clots, Muscular weakness, Neuralgia, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-01-22
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2023-01-23
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-14 | Pfizer-BioNTech | |
| 3 | 2022-01-21 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Mild soreness in deltoid with overhead reaching at times
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Didnt associate after the first vaccine, but after both vaccines my tongue was tingly and numb for about an hour after the vaccination
Release 12 — 6 months, dose 3
Symptoms: Inflammation throughout my body (face, neck, abdomen, upper and lower extremities), increased GI issues, increased nasal and upper respiratory congestion, deterioration of the deltoid where the vaccine was administered
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Injection site muscle atrophy | · | · | ✓ |
| SD | Menstrual clots | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
| SRO | Hypoaesthesia oral | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release